Cargando…

Epigenetic reprogramming in small cell lung cancer

Detalles Bibliográficos
Autores principales:	Chen, Jingyao, Pan, Xiangyu, Na, Feifei, Chen, Xuelan, Chen, Chong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425178/ https://www.ncbi.nlm.nih.gov/pubmed/36069525 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0343

Ejemplares similares

DNA methylation reprogramming in medaka fish, a promising animal model for environmental epigenetics research
por: Wang, Xuegeng, et al.
Publicado: (2020)

Linking Pluripotency Reprogramming and Cancer
por: Iglesias, Juan Manuel, et al.
Publicado: (2016)

Necessity of Epigenetic Epidemiology Studies on the Carcinogenesis of Lung Cancer in Never Smokers
por: Bae, Jong-Myon
Publicado: (2018)

Organelle remodeling in somatic cell reprogramming
por: Liu, Yang, et al.
Publicado: (2020)

Epigenetic drug library screening identified an LSD1 inhibitor to target UTX-deficient cells for differentiation therapy
por: Wu, Baohong, et al.
Publicado: (2019)

Organoid technology and applications in lung diseases: Models, mechanism research and therapy opportunities
por: Chen, Jingyao, et al.
Publicado: (2022)

Five Classic Articles in Somatic Cell Reprogramming
por: Park, In-Hyun
Publicado: (2010)

Identifying a confused cell identity for esophageal squamous cell carcinoma
por: Pan, Xiangyu, et al.
Publicado: (2022)

Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
por: Xiao, Wenjing, et al.
Publicado: (2021)

Metabostemness: Metaboloepigenetic reprogramming of cancer stem-cell functions
por: Menendez, Javier A., et al.
Publicado: (2014)

Epigenomic reprogramming in peripheral nerve injury
por: Ma, Ki H., et al.
Publicado: (2016)

Neuroregeneration using in vivo cellular reprogramming
por: Nguyen, Tu, et al.
Publicado: (2017)

Transcriptomic reprogramming for neuronal age reversal
por: Plesa, Alexandru M., et al.
Publicado: (2023)

Epigenetic reprogramming in the mammalian germline
por: Hsu, Fei-Man, et al.
Publicado: (2015)

MicroRNA‐mediated metabolic reprogramming of chimeric antigen receptor T cells
por: Rad, Seyed Mohammad Ali Hosseini, et al.
Publicado: (2022)

How to target small cell lung cancer
por: Hamilton, Gerhard, et al.
Publicado: (2015)

Epigenetic regulation of kidney progenitor cells
por: Huang, Biao, et al.
Publicado: (2020)

Epigenetic reprogramming of human lung cancer cells with the extract of bovine parthenogenetic oocytes
por: Wang, Zhenfei, et al.
Publicado: (2014)

Therapeutic revolution for inoperable stage III non-small cell lung cancer in the immune era
por: Li, Jiakang, et al.
Publicado: (2022)

Repositioning canakinumab for non-small cell lung cancer—important lessons for drug repurposing in oncology
por: Lythgoe, Mark P., et al.
Publicado: (2022)

A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung Cancer
por: Ramisetty, Sravani, et al.
Publicado: (2023)

Reprogramming the Methylome: Erasing Memory and Creating Diversity
por: Lee, Heather J., et al.
Publicado: (2014)

Epigenetic mechanisms in breast cancer therapy and resistance
por: Garcia-Martinez, Liliana, et al.
Publicado: (2021)

Generating oligodendroglia from adult mesenchymal cells for transplantation: cell reprogramming or direct lineage conversion?
por: Pascual-Guerra, Jorge, et al.
Publicado: (2022)

Spotlight on Tepotinib and Capmatinib for Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation
por: Brazel, Danielle, et al.
Publicado: (2022)

Neoadjuvant checkpoint inhibition in non-small cell lung cancer: Is earlier unquestionably better than later?
por: Olivier, Timothée, et al.
Publicado: (2022)

Cellular reprogramming and inherited peripheral neuropathies: perspectives and challenges
por: Saporta, Mario A.
Publicado: (2015)

In vivo astrocyte reprogramming following spinal cord injury
por: Gerber, Yannick N., et al.
Publicado: (2023)

BAP1 in cancer: epigenetic stability and genome integrity
por: Caporali, Sabrina, et al.
Publicado: (2022)

EGFR Inhibition in Non-Small Cell Lung Cancer: Resistance, Once Again, Rears Its Ugly Head
por: Clark, Jennifer, et al.
Publicado: (2005)

Epigenetic Reprogramming of Tumor-Associated Fibroblasts in Lung Cancer: Therapeutic Opportunities
por: Alcaraz, Jordi, et al.
Publicado: (2021)

Metabolic reprogramming of glial cells as a new target for central nervous system axon regeneration
por: Walden, Erin L., et al.
Publicado: (2021)

Epigenetics, Darwin, and Lamarck
por: Penny, David
Publicado: (2015)

Epigenetic reprogramming in liver fibrosis and cancer()
por: Wilson, Caroline L., et al.
Publicado: (2017)

Editorial: Epigenetic Reprogramming and Cancer Development
por: Brown, Geoffrey, et al.
Publicado: (2020)

Epigenetic reprogramming of breast cancer cells with oocyte extracts
por: Allegrucci, Cinzia, et al.
Publicado: (2011)

Adult neurogenesis and in vivo reprogramming: combining strategies for endogenous brain repair
por: Jones, Kathryn S., et al.
Publicado: (2016)

In vivo direct reprogramming as a therapeutic strategy for brain and retina repair
por: Sekiryu, Haruka, et al.
Publicado: (2021)

Immunotoxin Therapy for Lung Cancer
por: Xie, Li-Yi, et al.
Publicado: (2017)

A Canadian Perspective on the Challenges for Delivery of Curative-Intent Therapy in Stage III Unresectable Non-Small Cell Lung Cancer
por: Brade, Anthony, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j2iajl2q23o1oiiibqck1pm6j8